TY - JOUR
T1 - Energy cost of activity and exercise in children and adolescents with cystic fibrosis
AU - Johnson, Mark R.
AU - Ferkol, Thomas W.
AU - Shepherd, Ross W.
N1 - Funding Information:
The authors wish to thank Debb White R.P.F.T., R.R.T, Pamela Bates C.R.T.T., C.P.F.T., R.P.S.G., Gratia Telthorst and Sherrie Martin for their expert technical support during this project. We would also like to thank Lori Harper and Bradley Weinberger who were invaluable in their support of this project. We would also like to thank Washington University Cystic Fibrosis Center staff for their assistance in recruiting subjects. The work reported in this manuscript was supported by the Cystic Fibrosis Foundation. Finally, all research conformed to NIH guidelines, and the protocol was reviewed and approved by the Washington University School of Medicine Human Studies Committee.
PY - 2006/1
Y1 - 2006/1
N2 - In cystic fibrosis (CF), perturbations of total daily energy expenditure (TDEE) may be a major determinant of altered nutrition and growth. Measurement of TDEE is problematic, though the flex-heart rate method (FHRM) provides a close estimation of TDEE, as compared to the cost-prohibitive, gold standard, the double-labeled water method, and permits estimates of the energy cost of daily activities (ECA) above resting energy expenditure (REE). We hypothesize that alterations in ECA affects TDEE in CF. Purpose: To measure components of TDEE in adolescents with CF and normal lung function compared with controls, and to determine whether ECA can be improved by diet and exercise. Methods: Clinically stable CF subjects (aged 9-13, n=12) and age-and gender-matched controls (n=13) had repeated measurements of TDEE by FHRM, REE, and maximal cardiopulmonary exercise testing (CPET) during a 6-week exercise and diet program. Results: While the mean REE was similar in both groups, ECA was significantly lower in CF adolescents as compared to controls (p=0.02). During CPET, maximal exercise in CF was characterized by hyperventilation, which was unrelated to ventilation-perfusion mismatching. There were no changes in REE after dietary intervention. Conclusion: ECA in CF adolescents with normal lung function is lower when compared to healthy controls. These findings support the hypothesis that clinically stable patients with CF have inefficient energy metabolism or alternatively conserve energy during activities of daily living.
AB - In cystic fibrosis (CF), perturbations of total daily energy expenditure (TDEE) may be a major determinant of altered nutrition and growth. Measurement of TDEE is problematic, though the flex-heart rate method (FHRM) provides a close estimation of TDEE, as compared to the cost-prohibitive, gold standard, the double-labeled water method, and permits estimates of the energy cost of daily activities (ECA) above resting energy expenditure (REE). We hypothesize that alterations in ECA affects TDEE in CF. Purpose: To measure components of TDEE in adolescents with CF and normal lung function compared with controls, and to determine whether ECA can be improved by diet and exercise. Methods: Clinically stable CF subjects (aged 9-13, n=12) and age-and gender-matched controls (n=13) had repeated measurements of TDEE by FHRM, REE, and maximal cardiopulmonary exercise testing (CPET) during a 6-week exercise and diet program. Results: While the mean REE was similar in both groups, ECA was significantly lower in CF adolescents as compared to controls (p=0.02). During CPET, maximal exercise in CF was characterized by hyperventilation, which was unrelated to ventilation-perfusion mismatching. There were no changes in REE after dietary intervention. Conclusion: ECA in CF adolescents with normal lung function is lower when compared to healthy controls. These findings support the hypothesis that clinically stable patients with CF have inefficient energy metabolism or alternatively conserve energy during activities of daily living.
KW - Cardiopulmonary exercise testing
KW - Cystic fibrosis
KW - Energy expenditure
UR - http://www.scopus.com/inward/record.url?scp=31344448572&partnerID=8YFLogxK
U2 - 10.1016/j.jcf.2005.10.001
DO - 10.1016/j.jcf.2005.10.001
M3 - Article
C2 - 16360343
AN - SCOPUS:31344448572
SN - 1569-1993
VL - 5
SP - 53
EP - 58
JO - Journal of Cystic Fibrosis
JF - Journal of Cystic Fibrosis
IS - 1
ER -